- Home
- EPWK vs AEON Comparison
EPWK vs AEON Comparison
Compare EPWK & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- AEON
- Stock Information
- Founded
- EPWK 2011
- AEON N/A
- Country
- EPWK China
- AEON United States
- Employees
- EPWK N/A
- AEON N/A
- Industry
- EPWK
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- EPWK
- AEON Health Care
- Exchange
- EPWK Nasdaq
- AEON Nasdaq
- Market Cap
- EPWK 9.5M
- AEON 8.0M
- IPO Year
- EPWK 2025
- AEON N/A
- Fundamental
- Price
- EPWK $0.45
- AEON $0.77
- Analyst Decision
- EPWK
- AEON Strong Buy
- Analyst Count
- EPWK 0
- AEON 1
- Target Price
- EPWK N/A
- AEON $360.00
- AVG Volume (30 Days)
- EPWK 311.2K
- AEON 88.9K
- Earning Date
- EPWK 05-27-2025
- AEON 08-12-2025
- Dividend Yield
- EPWK N/A
- AEON N/A
- EPS Growth
- EPWK N/A
- AEON N/A
- EPS
- EPWK N/A
- AEON N/A
- Revenue
- EPWK $20,164,008.00
- AEON N/A
- Revenue This Year
- EPWK N/A
- AEON N/A
- Revenue Next Year
- EPWK N/A
- AEON N/A
- P/E Ratio
- EPWK N/A
- AEON N/A
- Revenue Growth
- EPWK 10.25
- AEON N/A
- 52 Week Low
- EPWK $0.41
- AEON $0.38
- 52 Week High
- EPWK $26.00
- AEON $115.57
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- AEON 53.21
- Support Level
- EPWK N/A
- AEON $0.66
- Resistance Level
- EPWK N/A
- AEON $0.80
- Average True Range (ATR)
- EPWK 0.00
- AEON 0.07
- MACD
- EPWK 0.00
- AEON 0.00
- Stochastic Oscillator
- EPWK 0.00
- AEON 81.40
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.